CHEN et al. v BOUCHARD et al. - Page 102



          Interference No. 103,675                                                      

    matter of any count in this interference.                                           
              Although we have held that Chen et al. failed in their brief              
    to meet their burden of persuasion in this proceeding, in an abundance              
    of caution we have undertaken to review the record for the purpose of               
    finding the underlying facts which support Chen et al.'s argued                     
    position from their brief that they actually reduced to practice six                
    compounds within the counts, specifically, BMS-46546; XXXVa; BMS-                   
    182902-01; BMS-183582-01; BMS-183583; and, BMS-183821-01. For reasons               
    set forth fully below, even considering the facts most favorably to                 
    Chen et al., Chen et al.'s argued position for being declared the                   
    first inventor of the subject matter of the counts is legally                       
    inadequate based on the record before us.                                           
              Dr. Chen's November memorandum to Drs. Vyas and Farina (CX                
    17), is directed to 7-fluoro derivatives not the cyclopropyl compounds              
    of the count. More significantly, as a memorandum written by Dr. Chen,              
    one of the named inventors, it cannot be considered as evidence                     
    independent of the inventor and cannot, therefore, be relied on as                  
    evidence of corroboration.                                                          
              Dr. Chen's notebook pages CX 18 and CX 19 which are relied                
    on as evidence of Dr. Chen's first experiments preparing compounds                  
    alleged to be within the counts are directed to the preparation of 7-               
    fluoro derivatives of taxol not cyclopropyl derivatives as required by              
                                       102                                              


Page:  Previous  95  96  97  98  99  100  101  102  103  104  105  106  107  108  109  Next 

Last modified: November 3, 2007